𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients

✍ Scribed by Fred K. L. Spijkervet; Hendrik K. F. Van Saene; Joris J. M. Van Saene; Arend K. Panders; Albert Vermey; Dinesz M. Mehta; Vasek Fidler

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
666 KB
Volume
46
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal evaluation of the oral muco
Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire
✍ Joel B. Epstein; Jennifer L. Beaumont; Clement K. Gwede; Barbara Murphy; Adam S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND. Quality‐of‐life instruments that measure specific functional consequences of mucositis are needed to assess the efficacy of therapeutic interventions targeted against mucositis and to guide patient care. The authors undertook a prospective, multicenter, observational stu

Effects of psychosocial intervention on
Effects of psychosocial intervention on quality of life in patients with head and neck cancer
✍ Karin M. Petruson; Ewa M. Silander; Eva B. Hammerlid 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Background. A longitudinal, prospective, case‐control study evaluated if a psychosocial support program improved health‐related quality of life (HRQL) in head and neck (H&N) cancer patients. ## Methods. One hundred forty‐four H&N cancer patients were included: 52 study patients an

Accuracy of positron emission tomography
Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer
✍ Richard C. W. Martin; Michael Fulham; Kerwin F. Shannon; Ceri Hughes; Kan Gao; C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Background The aim of this study was to evaluate the accuracy of positron emission tomography (PET) in assessing the patients treated with primary chemoradiotherapy for mucosal carcinoma of the head and neck. ## Methods A retrospective review of patients with biopsy‐proven cancer

Patient-reported measurements of oral mu
Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy : Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life
✍ Linda S. Elting; Dorothy M. Keefe; Stephen T. Sonis; Adam S. Garden; F. K. L. Sp 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 2 views

## Abstract ## BACKGROUND. The risk, severity, and patient‐reported outcomes of radiation‐induced mucositis among head and neck cancer patients were prospectively estimated. ## METHODS. A validated, patient‐reported questionnaire (OMDQ), the FACT quality of life (QOL), and the Functional Assessm

Mechanisms of immune suppression in pati
Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
✍ M. Rita I. Young; Mark A. Wright; Yvonne Lozano; John P. Matthews; Janet Benefie 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 789 KB

Freshly excised human head and neck cancers (2 I9 primary cancers; 64 metastatic lymph node cancers) were analyzed for the immune inhibitory mediators released from the cancer tissues and the immune infiltrate within the tumor. Significant levels of the immune inhibitory mediators transforming growt

Results of a pilot study of the effects
Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract
✍ Victor Lai; Jonathan George; Luther Richey; Hong J. Kim; Trinitia Cannon; Carol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## Background. Animal models suggest that cyclooxygenase‐2 (COX‐2) inhibitors may be beneficial in suppressing cancer cachexia. We investigated the effect of short‐course celecoxib on body composition, inflammation, and quality of life (QOL) in patients with cancer cachexia in a phase